from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0441c/-

LFCtreatmentdescriptionclass of inhibitor

0.147

Amikacinug/mL Amikacintranslation

0.080

Cap5-10ug/mL Capreomycintranslation

0.273

Rox10-50 ug/mL Roxithromycintranslation

-0.506

SM2-5 ug/mL Streptomycintranslation

-0.059

Tet5-10 ug/mL Tetracyclinetranslation

-2.229

Rif0.2-5ug/mL Rifampicintranscription

-0.197

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.818

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.956

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.160

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.383

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.569

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.663

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.715

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.878

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.307

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.393

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.920

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.098

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.188

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.683

KCN5-20 ug/mL Potassium cyaniderespiration

0.214

NaN30.2-2 mM Sodium aziderespiration

0.372

Nigericin50 uM Nigericinrespiration

0.945

TRC10-150 ug/mL Triclosanrespiration

0.970

TRZ10-25 ug/mL Thioridazinerespiration

1.067

Valinomycin0.5-10 uM Valinomycinrespiration

0.232

ZnSO42 mM ZnSO4respiration

0.220

menadione6-10 ug/mL Menadionerespiration

0.275

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.280

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.228

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.010

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.426

NRP_1Non-replicating persistence stage 1dosRassociated

-0.286

Amp0.2mg/mL AmpicillincellWall

-0.296

Cephalexin20-100 ug/mL CephalexincellWall

-0.249

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.479

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.251

EMB10-20 ug/mL EthambutolcellWall

0.184

Eta12-40 ug/mL EthionamidecellWall

0.164

INH0.2-0.4 ug/mL IsoniazidcellWall

0.118

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.724

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.718

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.230

BZA0.12 mg/mL BenzamidearomaticAmides

-0.270

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.145

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.795

H2O24 mM hydrogen peroxideDNAdamaging

-0.097

Levo10 ug/mL LevofloxacinDNAdamaging

-0.775

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.911

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.039

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.255

UVUV-irradiationDNAdamaging

0.780

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.933

Antimycin12.5-50 ug/mL Antimycin A?

-0.644

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.697

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.559

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.660

PA8240.2-2 ug/mL PA-824?

0.489

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.140

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.173

Verapamil50 uM Verapamil?

-0.504

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.732

methoxatin10-20 ug/mL Methoxatin?